Available on-demand. Login or create an account to register to view the recording.

This course was originally offered as part of "ORN - Hot Topics in Addiction Medicine - Spring 2022 Webinar Series (On-Demand)" course. If you took or registered for that course, you will not be able to access this course.

At the conclusion of this webinar, attendees will be able to:

• Demonstrate an understanding of epidemiology of stimulant use disorders with particularly important cultural factors and comorbidities that correspond with methamphetamine and cocaine use disorders. Use this understanding in developing culturally competent treatment plans
• Identify key neurobiology factors in development and maintenance of stimulant use disorder and how these relate to treatment options and treatment outcomes
• Understand the quality of and the extent of evidence supporting advancements in pharmacotherapies and behavioral therapies that can be brought into practice

How to claim your credits & download handouts for each webinar:

Under the "Course" tab (or "Content" tab):

1. Complete the required course materials.
2. Claim your credits by clicking the "Report Credit" or "Request Credit" button on the right above the course materials.

This webinar has been approved for a maximum 1, AOA Category 1-A CME credits, and AOA designates this for a maximum of 1, AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of the extent of their participation. This activity has been planned and implemented in accordance with the accreditation requirements and policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint providership of the American Osteopathic Association (AOA) and AOAAM. The AOA is accredited by the ACCME to provide continuing medical education for physicians.

Steven Shoptaw, PhD Steven Shoptaw PhD is Professor in UCLA Departments of Family Medicine and Psychiatry and Biobehavioral Sciences and Professor (Hon) in Psychiatry at the University of Cape Town. Dr. Shoptaw energetically leads research, clinical and policy efforts to bring novel and high impact strategies to deliver culturally competent care and prevention for persons affected by addictions and HIV. He leads two research centers at UCLA on addiction medicine and infectious diseases and is Protocol Co-Chair for an HIV Prevention Trials Network study evaluating a Mobile Health Delivery Unit to Link Persons who Inject Drugs to Integrated Care and Prevention for Addiction, HIV, HCV and Primary Care. Mentoring emerging clinical and research scholars from diverse backgrounds is a strong passion.